Allspring Global Investments
IMA

Allspring Global Investments’s ImageneBio Inc IMA Stock Holding History

Allspring Global Investments’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-140
Closed -$7.26K – 2464
2023
Q3 		$7.26K Buy
+140
New +$8.43K ﹤0.01% 2644

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Allspring Global Investments's IMA Position: Q4 2023 in Review

Allspring Global Investments sold out of ImageneBio Inc (IMA) in Q4 2023, closing a stake of 140 shares — an estimated $7.26K sold.

Allspring Global Investments first reported a position in IMA in Q3 2023 and held it in 1 quarter. The position peaked at $7.26K in Q3 2023. 54 funds tracked by Wall St. Rank hold IMA as of Q4 2023.

  • Allspring Global Investments reported no remaining ImageneBio Inc position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 140 ImageneBio Inc shares in Q4 2023, an estimated $7.26K.
  • Allspring Global Investments first reported a position in ImageneBio Inc in Q3 2023 and held it in 1 quarter.
  • Allspring Global Investments's ImageneBio Inc position peaked at $7.26K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.